Augmented cardiac growth hormone signaling contributes to cardiomyopathy following genetic disruption of the cardiomyocyte circadian clock

Authors

Ravi Sonkar, University of Alabama at Birmingham
Ryan Berry, University of Alabama at Birmingham
Mary N Latimer, University of Alabama at Birmingham
Sumanth D Prabhu, Washington University School of Medicine in St. Louis
Martin E Young, University of Alabama at Birmingham
Stuart J Frank, University of Alabama at Birmingham

Journal

Frontiers in Pharmacology

Publication Date

1-1-2022

Volume

13

First Page

836725

Document Type

Open Access Publication

DOI

10.3389/fphar.2022.836725

Rights and Permissions

Sonkar R, Berry R, Latimer MN, Prabhu SD, Young ME and Frank SJ (2022) Augmented Cardiac Growth Hormone Signaling Contributes to Cardiomyopathy Following Genetic Disruption of the Cardiomyocyte Circadian Clock. Front. Pharmacol. 13:836725. doi.org/10.3389/fphar.2022.836725 © 2022 Sonkar, Berry, Latimer, Prabhu, Young and Frank. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Recommended Citation

Sonkar, Ravi; Berry, Ryan; Latimer, Mary N; Prabhu, Sumanth D; Young, Martin E; and Frank, Stuart J, "Augmented cardiac growth hormone signaling contributes to cardiomyopathy following genetic disruption of the cardiomyocyte circadian clock." Frontiers in Pharmacology. 13, 836725 (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11579